ProShares Ultra Nasdaq Biotechnology (BIB)

52.19 +0.78 (+1.52%) USD  |  NASDAQ  |  Dec 24, 16:00
More

BIB Alpha (vs YCharts Benchmark) (3Y)

Alpha (vs YCharts Benchmark) (3Y) Chart

View Alpha (vs YCharts Benchmark) (3Y) for BIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Alpha (vs YCharts Benchmark) (3Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Alpha Definition

View Alpha Definition
Start Trial

Alpha measures the excess return that a security provides. Alpha can be measured by taking Risk Adjusted Security Return - Beta*(Risk Adjusted Market Return). This formula will return the outperformance that the security provides. Alpha is an important metric for active investing, where investors look for outperforming a particular benchmark.

Read full definition.

Alpha (vs YCharts Benchmark) (3Y) Range, Past 5 Years

View Alpha (vs YCharts Benchmark) (3Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Alpha (vs YCharts Benchmark) (3Y) Benchmarks

View Alpha (vs YCharts Benchmark) (3Y) Benchmarks
Start Trial
ProShares Ultra Real Estate Upgrade
Direxion Daily Real Estate Bull 3X Shares Upgrade
Direxion Daily S&P 500 High Beta Bull 3X Shares Upgrade
Direxion Daily Gold Miners Index Bull 2X Shares Upgrade
Invesco Nasdaq Biotechnology ETF Upgrade

Alpha (vs YCharts Benchmark) (3Y) Related Metrics

Alpha (3Y) Upgrade
Beta (3Y) Upgrade
Beta (vs YCharts Benchmark) (3Y) Upgrade
Annualized Standard Deviation of Monthly Returns (3Y Lookback) Upgrade
Historical Sharpe Ratio (3Y) Upgrade
Historical Sortino (3Y) Upgrade
Max Drawdown (3Y) Upgrade
Monthly Value at Risk (VaR) 5% (3Y Lookback) Upgrade